Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-07 Sale | 2025-03-11 4:33 pm | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 200 | $30.02 | $6,004 | 1,471,443 (Direct) | View |
| 2025-03-07 Sale | 2025-03-11 4:32 pm | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 100 | $30 | $3,000 | 394,807 (Indirect Direct) | View |
| 2025-02-05 Sale | 2025-02-07 4:38 pm | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 9,215 | $30.04 | $276,776 | 2,711,193 (Direct) | View |
| 2025-02-05 Sale | 2025-02-07 4:38 pm | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 9,536 | $30.13 | $287,316 | 437,452 (Indirect Direct) | View |
| 2025-02-05 Sale | 2025-02-07 4:37 pm | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 10,000 | $30.03 | $300,300 | 109,766 (Direct) | View |
| 2025-01-28 Sale | 2025-01-30 4:05 pm | Edgewise Therapeutics Inc. | EWTX | Donovan Joanne M. CMO | 25,000 | $27.63 | $690,658 | 191,358 (Direct) | View |
| 2024-12-30 Sale | 2024-12-31 5:13 pm | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 100,000 | $27.37 | $2,737,470 | 1,371,643 (Direct) | View |
| 2024-12-24 Sale | 2024-12-27 4:30 pm | Edgewise Therapeutics Inc. | EWTX | Semigran Marc Chief Development Officer | 29,709 | $29.69 | $881,915 | 277,007 (Direct) | View |
| 2024-09-20 Sale | 2024-09-24 8:25 pm | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 75,000 | $28.27 | $2,120,101 | 1,469,499 (Direct) | View |
| 2024-09-20 Sale | 2024-09-24 8:25 pm | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 70,922 | $28.15 | $1,996,574 | 107,446 (Direct) | View |
| 2024-09-20 Sale | 2024-09-24 8:24 pm | Edgewise Therapeutics Inc. | EWTX | Donovan Joanne M. CMO | 7,162 | $28.29 | $202,603 | 14,538 (Direct) | View |
| 2024-09-20 Sale | 2024-09-24 8:24 pm | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 42,068 | $29.03 | $1,221,133 | 118,070 (Direct) | View |
| 2024-09-20 Sale | 2024-09-24 8:22 pm | Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer | 125,092 | $28.57 | $3,573,980 | 47,894 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 6:31 pm | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 1,956 | $18.91 | $36,988 | 8,461 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 6:30 pm | Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer | 2,157 | $18.91 | $40,789 | 40,439 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 6:29 pm | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 1,718 | $18.91 | $32,487 | 18,631 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 6:28 pm | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 1,576 | $18.91 | $29,802 | 12,447 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 6:27 pm | Edgewise Therapeutics Inc. | EWTX | Donovan Joanne M. CMO | 3,682 | $18.91 | $69,627 | 30,314 (Direct) | View |
| 2024-05-02 Sale | 2024-05-03 6:26 pm | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 3,152 | $18.91 | $59,604 | 363,679 (Indirect Direct) | View |
| 2024-02-07 Sale | 2024-02-09 5:43 pm | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 29,835 | $20 | $596,805 | 299,357 (Direct) | View |
| 2024-02-07 Sale | 2024-02-09 5:42 pm | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 10,000 | $20.03 | $200,258 | 456,271 (Direct) | View |
| 2024-01-23 Sale | 2024-01-25 4:46 pm | Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer | 90,000 | $15.78 | $1,419,759 | 166,082 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-07 Exercise | 2025-03-11 4:33 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 200 | $0.18 | 1,471,443 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-11 4:33 pm | N/A 2032-06-27 | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 200 | $0 | 1,471,443 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-11 4:32 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 100 | $0.18 | 394,807 (Direct) | View |
| 2025-03-07 Exercise | 2025-03-11 4:32 pm | 2021-06-13 2027-08-08 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 100 | $0 | 394,807 (Direct) | View |
| 2025-02-05 Exercise | 2025-02-07 4:38 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 9,215 | $0.18 | 2,711,193 (Direct) | View |
| 2025-02-05 Exercise | 2025-02-07 4:38 pm | 2021-06-27 2032-06-27 | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 9,215 | $0 | 2,711,193 (Direct) | View |
| 2025-02-05 Exercise | 2025-02-07 4:38 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 8,636 | $0.18 | 437,452 (Direct) | View |
| 2025-02-06 Exercise | 2025-02-07 4:38 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 900 | $13.11 | 437,452 (Direct) | View |
| 2025-02-05 Exercise | 2025-02-07 4:38 pm | 2021-06-13 2027-08-08 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 9,536 | $0 | 437,452 (Direct) | View |
| 2025-02-05 Exercise | 2025-02-07 4:37 pm | 2024-12-03 2030-12-15 | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 10,000 | $0 | 109,766 (Direct) | View |
| 2025-02-05 Exercise | 2025-02-07 4:37 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 10,000 | $1.93 | 109,766 (Direct) | View |
| 2025-01-28 Exercise | 2025-01-30 4:05 pm | N/A 2033-08-17 | Edgewise Therapeutics Inc. | EWTX | Donovan Joanne M. CMO | 25,000 | $0 | 191,358 (Direct) | View |
| 2025-01-28 Exercise | 2025-01-30 4:05 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Donovan Joanne M. CMO | 25,000 | $7.08 | 191,358 (Direct) | View |
| 2025-01-21 Option Award | 2025-01-23 7:56 pm | N/A 2035-01-21 | Edgewise Therapeutics Inc. | EWTX | Blaustein Robert Chief Development Officer | 190,000 | $0 | 190,000 (Direct) | View |
| 2024-12-30 Exercise | 2024-12-31 5:13 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 100,000 | $0.18 | 1,371,643 (Direct) | View |
| 2024-12-30 Exercise | 2024-12-31 5:13 pm | 2021-06-27 2032-06-27 | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 100,000 | $0 | 1,371,643 (Direct) | View |
| 2024-12-24 Exercise | 2024-12-27 4:30 pm | N/A 2032-12-30 | Edgewise Therapeutics Inc. | EWTX | Semigran Marc Chief Development Officer | 29,709 | $0 | 277,007 (Direct) | View |
| 2024-12-24 Exercise | 2024-12-27 4:30 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Semigran Marc Chief Development Officer | 29,709 | $8.94 | 277,007 (Direct) | View |
| 2024-10-11 Exercise | 2024-10-16 4:23 pm | 2024-09-01 2030-09-01 | Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer | 70,000 | $0 | 204,026 (Direct) | View |
| 2024-10-11 Exercise | 2024-10-16 4:23 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer | 70,000 | $0.71 | 204,026 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-24 8:25 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 75,000 | $0.18 | 1,469,499 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-24 8:25 pm | N/A 2032-06-27 | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 75,000 | $0 | 1,469,499 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-24 8:25 pm | N/A 2030-09-01 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 70,922 | $0 | 107,446 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-24 8:25 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 70,922 | $0.71 | 107,446 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-24 8:24 pm | N/A 2030-12-15 | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 42,068 | $0 | 118,070 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-24 8:24 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 42,068 | $1.93 | 118,070 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-24 8:22 pm | N/A 2030-12-15 | Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer | 96,068 | $0 | 47,894 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-24 8:22 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer | 96,068 | $1.93 | 47,894 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-14 4:15 pm | N/A 2034-08-12 | Edgewise Therapeutics Inc. | EWTX | Semigran Marc Chief Development Officer | 161,875 | $0 | 161,875 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-14 4:15 pm | N/A 2034-08-12 | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 161,875 | $0 | 161,875 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-14 4:15 pm | N/A 2034-08-12 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 161,875 | $0 | 161,875 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-14 4:14 pm | N/A 2034-08-12 | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 161,875 | $0 | 161,875 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-14 4:14 pm | N/A 2034-08-12 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 503,125 | $0 | 503,125 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-14 4:14 pm | N/A 2034-08-12 | Edgewise Therapeutics Inc. | EWTX | Donovan Joanne M. CMO | 161,875 | $0 | 161,875 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-14 4:13 pm | N/A 2034-08-12 | Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer | 161,875 | $0 | 161,875 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-12 7:33 pm | 2025-06-10 2034-06-10 | Edgewise Therapeutics Inc. | EWTX | Thompson Peter A. Director 10% Owner | 20,594 | $0 | 20,594 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-12 7:32 pm | 2025-06-10 2034-06-10 | Edgewise Therapeutics Inc. | EWTX | Fox Jonathan C Director | 20,594 | $0 | 20,594 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-12 7:26 pm | 2025-06-10 2034-06-10 | Edgewise Therapeutics Inc. | EWTX | Morris Arlene Director | 20,594 | $0 | 20,594 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-12 7:25 pm | 2025-06-10 2034-06-10 | Edgewise Therapeutics Inc. | EWTX | Brege Laura Director | 20,594 | $0 | 20,594 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-12 7:23 pm | 2025-06-10 2034-06-10 | Edgewise Therapeutics Inc. | EWTX | Edris Badreddin Director | 20,594 | $0 | 20,594 (Direct) | View |
| 2024-06-10 Option Award | 2024-06-12 7:22 pm | 2025-06-10 2034-06-10 | Edgewise Therapeutics Inc. | EWTX | ROOT JONATHAN D Director | 20,594 | $0 | 20,594 (Direct) | View |
| 2024-05-06 Option Award | 2024-05-07 7:52 pm | N/A 2034-05-06 | Edgewise Therapeutics Inc. | EWTX | Morris Arlene Director | 34,311 | $0 | 34,311 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-03 6:31 pm | N/A 2032-05-01 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 5,208 | $0 | 8,461 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-03 6:30 pm | N/A 2032-05-01 | Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer | 5,208 | $0 | 40,439 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-03 6:29 pm | N/A 2032-05-01 | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 5,208 | $0 | 18,631 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-03 6:28 pm | N/A 2032-05-01 | Edgewise Therapeutics Inc. | EWTX | Russell Alan J Chief Scientific Officer | 5,208 | $0 | 12,447 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-03 6:27 pm | N/A 2032-05-01 | Edgewise Therapeutics Inc. | EWTX | Donovan Joanne M. CMO | 10,417 | $0 | 30,314 (Direct) | View |
| 2024-05-01 Exercise | 2024-05-03 6:26 pm | N/A 2032-05-01 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 10,417 | $0 | 363,679 (Direct) | View |
| 2024-02-07 Exercise | 2024-02-09 5:43 pm | N/A 2030-12-15 | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 29,835 | $0 | 299,357 (Direct) | View |
| 2024-02-07 Exercise | 2024-02-09 5:43 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | MOORE JOHN R General Counsel | 29,835 | $1.93 | 299,357 (Direct) | View |
| 2024-02-07 Exercise | 2024-02-09 5:42 pm | N/A 2030-12-15 | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 10,000 | $0 | 456,271 (Direct) | View |
| 2024-02-07 Exercise | 2024-02-09 5:42 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer | 10,000 | $1.93 | 456,271 (Direct) | View |
| 2024-01-23 Exercise | 2024-01-25 4:46 pm | N/A 2030-12-15 | Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer | 90,000 | $0 | 166,082 (Direct) | View |
| 2024-01-23 Exercise | 2024-01-25 4:46 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | Carruthers R Michael Chief Financial Officer | 90,000 | $1.93 | 166,082 (Direct) | View |